HC Wainwright Issues Positive Forecast for BiomX (NYSEAMERICAN:PHGE) Stock Price

BiomX (NYSEAMERICAN:PHGE) had its target price boosted by HC Wainwright from $2.00 to $21.00 in a research report sent to investors on Tuesday,Benzinga reports. The firm currently has a buy rating on the stock.

BiomX Stock Down 11.3 %

Shares of BiomX stock opened at $0.49 on Tuesday. BiomX has a fifty-two week low of $0.48 and a fifty-two week high of $4.99. The firm has a market capitalization of $8.96 million, a PE ratio of -0.15 and a beta of 1.27.

BiomX Company Profile

BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).